Clinical trials

ECLIPSE: Lu-177-PSMA-I&T for metastic Castration-Resistant Prostate Cancer

Condition

metastatic Castration-Resistant Prostate Cancer (mCRPC)

ClinicalTrials.gov identifier

NCT

Interventions

Intervention Type: Drug
Intervention Name: Lu-177-PSMA-I&T
Intervention Description: Intravenous radioligand therapy

Curium reference number

CURLu177PSM001

Phase

Phase 3

Protocol Title

Purpose

Contact